Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

CORT

20 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in Corcept Therapeutics Incorporated

Yes. Connor, Clark & Lunn Investment Management holds 81,569 shares of CORT (Corcept Therapeutics), worth $7.1M, as of its Q2 2026 13F filing. It reduced the position by 36,385 shares (-30.9%) from Q1 2026. Connor, Clark & Lunn Investment Management has held CORT since Q3 2021, across 20 quarterly 13F filings.

Current Value

$7.1M

Current Shares

81,569

Total Value Change

+$6.9M

Total Shares Change

+69,719

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
81,569
-30.9%
$7.1M0.0%$86.95
0
2026-Q1
Decreased
117,954
-46.7%
$4.8M0.0%$40.31
0
2025-Q4
Decreased
221,444
-40.1%
$7.7M0.0%$34.80
0
2025-Q3
Increased
369,869
+16.3%
$30.7M0.1%$83.11
33
2025-Q2
Decreased
318,005
-57.7%
$23.3M0.1%$73.40
0
2025-Q1
Decreased
751,218
-5.7%
$85.8M0.4%$114.22
0
2024-Q4
Decreased
796,795
-7.3%
$40.2M0.2%$50.39
0
2024-Q3
Increased
859,563
+20.0%
$39.8M0.2%$46.28
41
2024-Q2
Increased
716,056
+32.1%
$23.3M0.1%$32.49
36
2024-Q1
Increased
542,178
+50.1%
$13.7M0.1%$25.19
39
2023-Q4
Decreased
361,207
-0.3%
$11.7M0.1%$32.48
0
2023-Q3
Decreased
362,436
-0.1%
$9.9M0.1%$27.25
0
2023-Q2
Increased
362,908
+64.2%
$8.1M0.0%$22.25
40
2023-Q1
Increased
221,012
+59.3%
$4.8M0.0%$21.66
39
2022-Q4
Increased
138,743
+68.6%
$2.8M0.0%$20.31
39
2022-Q3
Increased
82,298
+10.2%
$2.1M0.0%$25.64
29
2022-Q2
Decreased
74,664
-45.7%
$1.8M0.0%$23.78
0
2022-Q1
Increased
137,550
+186.0%
$3.1M0.0%$22.52
43
2021-Q4
Increased
48,101
+305.9%
$952,0000.0%$19.80
40
2021-Q3
New
11,850
-
$233,0000.0%$19.68
32

Other major holders of CORT: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used